Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

Amgen (NASDAQ:AMGN) raised its share repurchase program by $5 billion. With $1.5 billion remaining under the previous program, the total repurchase authorization is now $6.5 billion.

Amgen discovers, develops and delivers innovative human therapeutics.



With 1.16 billion shares outstanding, the Total Payout of the $6.5 billion program will be $5.60 per share if completed over the next 4 quarters.  At $56 per share, that would produce a Total Payout Yield of 10%.

- Payout Yield Staff


Subscribe to our e-mail newsletter to receive updates.